Chronic renal failure (CRF) patients display endothelial dysfunction characterized by an impairment of endothelium-dependent vasodilatation [ 1 x 1. Kari, J.A., Donald, A.E., Vallance, D.T. et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997; 52: 468–472 Abstract | Full Text PDF | PubMed | Scopus (195) | Google Scholar See all References ] [1] , and an increase in plasma levels of endothelial molecules involved in vascular tone, hemostasis, or adhesion [ 2. x 2. Warrens, A.N., Cassidy, M.J., Takahashi, K. et al. Endothelin in renal failure. Nephrol Dial Transplant. 1990; 5: 418–422 Crossref | PubMed | Scopus (85) | Google Scholar See all References , 3. x 3. Takagi, M., Wada, H., Mukai, K. et al. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance hemodialysis. Blood Coagul Fibrinolysis. 1994; 5: 713–717 Crossref | PubMed | Scopus (48) | Google Scholar See all References , 4. x 4. Gris, J.C., Branger, B., Vecina, F. et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int. 1994; 46: 807–813 Abstract | Full Text PDF | PubMed | Scopus (129) | Google Scholar See all References , 5. x 5. Bonomini, M., Reale, M., Santarelli, P. et al. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron. 1998; 79: 399–407 Crossref | PubMed | Scopus (119) | Google Scholar See all References ]. It has been suggested that uremic solutes, which accumulate in CRF patients, are among the factors involved in this endothelial dysfunction. In vitro, some uremic retention solutes induce endothelial dysfunction. Homocysteine up-regulates the gene coding for a stress protein [ 6 x 6. Kokame, K., Kato, H., and Miyata, T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J Biol Chem. 1996; 271: 29659–29665 Crossref | PubMed | Scopus (278) | Google Scholar See all References ] [6] , p-cresol inhibits endothelial cell response to inflammatory cytokines [ 7 x 7. Dou, L., Cerini, C., Brunet, P. et al. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int. 2002; 62: 1999–2009 Abstract | Full Text | Full Text PDF | PubMed | Scopus (76) | Google Scholar See all References ] [7] , and advanced glycation end products (AGEs) up-regulate the expression of endothelial adhesion molecules [ 8 x 8. Sengoelge, G., Fodinger, M., Skoupy, S. et al. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int. 1998; 54: 1637–1651 Abstract | Full Text | Full Text PDF | PubMed | Scopus (49) | Google Scholar See all References ] [8] , and increase endothelial permeability [ 9 x 9. Wautier, J.L., Zoukourian, C., Chappey, O. et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest. 1996; 97: 238–243 Crossref | PubMed | Scopus (440) | Google Scholar See all References ] [9] .

In CKD, uremic solutes may induce endothelial dysfunction, inflammation, and oxidative stress, leading to increased cardiovascular risk. We investigated whether the uremic solute indole-3 acetic acid (IAA) predicts clinical outcomes in patients with CKD and has prooxidant and proinflammatory effects. We studied 120 patients with CKD. During the median study period of 966 days, 29 patients died and 35 experienced a major cardiovascular event. Kaplan–Meier analysis revealed that mortality and cardiovascular events were significantly higher in the higher IAA group (IAA>3.73 µM) than in the lower IAA group (IAA<3.73 µM). Multivariate Cox regression analysis demonstrated that serum IAA was a significant predictor of mortality and cardiovascular events after adjustments for age and sex; cholesterol, systolic BP, and smoking; C-reactive protein, phosphate, body mass index, and albumin; diastolic BP and history of cardiovascular disease; and uremic toxins p-cresyl sulfate and indoxyl sulfate. Notably, IAA level remained predictive of mortality when adjusted for CKD stage. IAA levels were positively correlated with markers of inflammation and oxidative stress: C-reactive protein and malondialdehyde, respectively. In cultured human endothelial cells, IAA activated an inflammatory nongenomic aryl hydrocarbon receptor (AhR)/p38MAPK/NF-κB pathway that induced the proinflammatory enzyme cyclooxygenase-2. Additionally, IAA increased production of endothelial reactive oxygen species. In conclusion, serum IAA may be an independent predictor of mortality and cardiovascular events in patients with CKD. In vitro, IAA induces endothelial inflammation and oxidative stress and activates an inflammatory AhR/p38MAPK/NF-κB pathway.